ENP109: Anti-Obesity Medications

<p><span style="color: rgb(44, 42, 41);">In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, but also in the medications themselves, how effective they are, how many there are. What exactly has changed during this rapid evolution? How safe and effective are these medications today? What challenges still exist in using them? To help answer these questions, host Aaron Lohr speaks with&nbsp;</span><strong style="color: rgb(44, 42, 41);">Gitanjali Srivastava, MD</strong><span style="color: rgb(44, 42, 41);">, professor of medicine, medical director of Vanderbilt Obesity Medicine, and founding program director of the Obesity Medicine Fellowship at Vanderbilt University Medical Center. Dr. Srivastava presented at the Endocrine Society’s Obesity Fellows Conference in September 2025. The title of her presentation was “Pharmacological Approaches to Treating and Understanding Complicated Obesity.” Listening to this episode can earn you 0.5 ABIM MOC points and 0.5 AMA PRA Category 1 credits. If you are interested in those points and credits, you will need to take a pre-test on the Endocrine Society Center for Learning before listening to this episode.&nbsp;</span><strong style="color: rgb(44, 42, 41);"><em>Please look below for the appropriate link.</em></strong><span style="color: rgb(44, 42, 41);">&nbsp;After that pre-test, listen to this episode&nbsp;</span><em style="color: rgb(44, 42, 41);">in the Center for Learning</em><span style="color: rgb(44, 42, 41);">, then take the post-test. This episode is made possible by educational grants from Lilly and Novo Nordisk.</span></p>